Krista Y Hu1, Robert C Bauer. 1. Cardiometabolic Genomics Program, Division of Cardiology, Department of Medicine, Columbia University, New York, New York, USA.
Abstract
PURPOSE OF REVIEW: The pseudokinase Tribbles-1 (TRIB1) remains the focus of intense research since genome-wide association studies (GWAS) associated it with multiple cardiometabolic traits in humans, including plasma lipids and atherosclerosis. This review highlights recent advances in understanding the function of TRIB1 and what outstanding questions remain. RECENT FINDINGS: Studies performed in a myeloid-specific Trib1 mouse model show that Trib1 contributes to foam cell formation, underscoring the importance of continued research into tissue-specific functions of TRIB1. Investigations of TRIB1 function in a 3D hepatic organoid model demonstrate that hepatic TRIB1 functions elucidated in mouse models are recapitulated in these organoid systems. Lastly, a recent study showed berberine, an existing lipid-lowering drug, to be acting via a TRIB1-dependent mechanism, highlighting both a novel regulator of TRIB1 expression and the potential of studying TRIB1 through existing therapeutics. SUMMARY: TRIB1 remains one of the more fascinating loci to arise from cardiometabolic GWAS, given the constellation of traits it associates with. As genetic studies continue to link TRIB1 to metabolic phenotypes, more functional research on tissue-specific TRIB1, regulation of TRIB1 and its function in current therapies, as well as the reproduction of results from mice in human contexts are all necessary to increase our understanding of TRIB1 and its relevance.
PURPOSE OF REVIEW: The pseudokinase Tribbles-1 (TRIB1) remains the focus of intense research since genome-wide association studies (GWAS) associated it with multiple cardiometabolic traits in humans, including plasma lipids and atherosclerosis. This review highlights recent advances in understanding the function of TRIB1 and what outstanding questions remain. RECENT FINDINGS: Studies performed in a myeloid-specific Trib1 mouse model show that Trib1 contributes to foam cell formation, underscoring the importance of continued research into tissue-specific functions of TRIB1. Investigations of TRIB1 function in a 3D hepatic organoid model demonstrate that hepatic TRIB1 functions elucidated in mouse models are recapitulated in these organoid systems. Lastly, a recent study showed berberine, an existing lipid-lowering drug, to be acting via a TRIB1-dependent mechanism, highlighting both a novel regulator of TRIB1 expression and the potential of studying TRIB1 through existing therapeutics. SUMMARY: TRIB1 remains one of the more fascinating loci to arise from cardiometabolic GWAS, given the constellation of traits it associates with. As genetic studies continue to link TRIB1 to metabolic phenotypes, more functional research on tissue-specific TRIB1, regulation of TRIB1 and its function in current therapies, as well as the reproduction of results from mice in human contexts are all necessary to increase our understanding of TRIB1 and its relevance.
Authors: Ethan A Mack; Sarah J Stein; Kelly S Rome; Lanwei Xu; Gerald B Wertheim; Rossana C N Melo; Warren S Pear Journal: Blood Date: 2019-03-27 Impact factor: 22.113
Authors: Robert C Bauer; Makoto Sasaki; Daniel M Cohen; Jian Cui; Mikhaila A Smith; Batuhan O Yenilmez; David J Steger; Daniel J Rader Journal: J Clin Invest Date: 2015-09-08 Impact factor: 14.808
Authors: Rick B Vega; Bram Brouwers; Stephanie A Parsons; Natalie A Stephens; Maria F Pino; Andrew Hodges; Fanchao Yi; Gongxin Yu; Richard E Pratley; Steven R Smith; Lauren M Sparks Journal: Physiol Rep Date: 2020-06
Authors: Jessica M Johnston; Adrienn Angyal; Robert C Bauer; Stephen Hamby; S Kim Suvarna; Kajus Baidžajevas; Zoltan Hegedus; T Neil Dear; Martin Turner; Heather L Wilson; Alison H Goodall; Daniel J Rader; Carol C Shoulders; Sheila E Francis; Endre Kiss-Toth Journal: Sci Adv Date: 2019-10-30 Impact factor: 14.136
Authors: Steven Bell; Andreas S Rigas; Magnus K Magnusson; Egil Ferkingstad; Elias Allara; Gyda Bjornsdottir; Anna Ramond; Erik Sørensen; Gisli H Halldorsson; Dirk S Paul; Kristoffer S Burgdorf; Hannes P Eggertsson; Joanna M M Howson; Lise W Thørner; Snaedis Kristmundsdottir; William J Astle; Christian Erikstrup; Jon K Sigurdsson; Dragana Vuckovic; Khoa M Dinh; Vinicius Tragante; Praveen Surendran; Ole B Pedersen; Brynjar Vidarsson; Tao Jiang; Helene M Paarup; Pall T Onundarson; Parsa Akbari; Kaspar R Nielsen; Sigrun H Lund; Kristinn Juliusson; Magnus I Magnusson; Michael L Frigge; Asmundur Oddsson; Isleifur Olafsson; Stephen Kaptoge; Henrik Hjalgrim; Gudmundur Runarsson; Angela M Wood; Ingileif Jonsdottir; Thomas F Hansen; Olof Sigurdardottir; Hreinn Stefansson; David Rye; James E Peters; David Westergaard; Hilma Holm; Nicole Soranzo; Karina Banasik; Gudmar Thorleifsson; Willem H Ouwehand; Unnur Thorsteinsdottir; David J Roberts; Patrick Sulem; Adam S Butterworth; Daniel F Gudbjartsson; John Danesh; Søren Brunak; Emanuele Di Angelantonio; Henrik Ullum; Kari Stefansson Journal: Commun Biol Date: 2021-02-03
Authors: Derek Klarin; Scott M Damrauer; Kelly Cho; Yan V Sun; Tanya M Teslovich; Jacqueline Honerlaw; David R Gagnon; Scott L DuVall; Jin Li; Gina M Peloso; Mark Chaffin; Aeron M Small; Jie Huang; Hua Tang; Julie A Lynch; Yuk-Lam Ho; Dajiang J Liu; Connor A Emdin; Alexander H Li; Jennifer E Huffman; Jennifer S Lee; Pradeep Natarajan; Rajiv Chowdhury; Danish Saleheen; Marijana Vujkovic; Aris Baras; Saiju Pyarajan; Emanuele Di Angelantonio; Benjamin M Neale; Aliya Naheed; Amit V Khera; John Danesh; Kyong-Mi Chang; Gonçalo Abecasis; Cristen Willer; Frederick E Dewey; David J Carey; John Concato; J Michael Gaziano; Christopher J O'Donnell; Philip S Tsao; Sekar Kathiresan; Daniel J Rader; Peter W F Wilson; Themistocles L Assimes Journal: Nat Genet Date: 2018-10-01 Impact factor: 38.330